Journals

Catch up on selected 2025-2026 conference data across AD, CHE, GPP, and PG, including symptom burden, long-term disease impact, and…

Chronic hepatitis B affects approximately 1.7 million people in the United States and represents a significant public health challenge…

COPD remains one of the leading causes of morbidity and mortality in the USA, contributing to thousands of emergency visits…

The European Society for Medical Oncology (ESMO) Annual Congress was held in Berlin, Germany between October 17th–21st, 2025…

Regina Berkovich and Robert Shin share their insights for this article on the evolving role of a selective S1P receptor modulator in early relapsing MS…

Treatment of early breast cancer (eBC) is continuing to advance, and pivotal PhaseIII trial data released at the San Antonio Breast Cancer…

Invasive fungal infections remain a serious concern in patients with hematologic malignancies. In this expert interview, Hana F. Safah…

JAK inhibitors have expanded options for managing alopecia areata, but questions remain around patient selection, monitoring, and…